Pill vs. injection: new hope for dialysis Patients' anemia?
NCT ID NCT07300111
Summary
This study is testing if a new oral pill called daprodustat (QLG1218) is as safe and effective as standard injection treatments for anemia in adults with chronic kidney disease who are on dialysis. About 100 participants in China will be randomly assigned to receive either the new pill or the standard injection (darbepoetin alfa) for about 32 weeks. The main goal is to see if the pill can control hemoglobin levels as well as the injection.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.